Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: A cohort study

Affiliations

• ¹ Leicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK.
• ² Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
• ³ Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, UK.
• ⁴ Department of Medicine, University of Toronto; Division of Endocrinology, Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
• ⁵ Cancer Research UK Oxford Centre, University of Oxford, Oxford, UK.
• ⁶ Primary Care Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
• ⁷ MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
• ⁸ Primary Care Research Centre, University of Southampton, Southampton, UK.